Over the past week, China biopharma has witnessed a remarkable series of milestones, as major players have opened new facilities or announced plans to expand. Most of the activity has been centered in Shanghai, especially in the biopharma-rich Zhangjiang Park. Three Shanghai-based CROs held their Grand Opening ceremonies for new labs, while two international big pharmas inaugurated new offices or announced plans for expansion. More details..

Stock Symbols: (NYSE: LLY) (NYSE: SNY) (NYSE: CRL) (AIM: HCM)